Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tsao YY et al. - Supratherapeutic flecainide plasma concentrations may cause delirium. Because toxicity may occur when flecainide is prescribed with paroxetine and other potent CYP2D6 inhibitors, flecainide plasma concentrations should be monitored closely with commencement of CYP2D6 inhibitors.

Related Articles

Postoperative Delirium in the Elderly Surgical Patient
Anesthesiology Clinics, 10/16/09    Relevance Score: 93%

Acute Confusion/Delirium: Identification, Assessment, Treatment, and Prevention
Journal of Gerontological Nursing, 11/16/09    Relevance Score: 92%

The Assessment and Management of Delirium in Cancer Patients
The Oncologist, 10/28/09    Relevance Score: 90%

Symptoms of Depression and Delirium Assessed Serially in Palliative-Care Inpatients
Psychosomatics, 10/28/09    Relevance Score: 89%

Delirium in patients admitted to a step-down unit: Analysis of incidence and risk factors
Journal of Critical Care, 10/01/09    Relevance Score: 88%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address